# Critic Response

- Package: `jama.2025.16450`
- Stage: single critic stage completed
- Input reviewed: `.ai_paper_validation/agent_responses/evidence_verifier.md`
- Candidate scope: C-01 through C-05 only
- Evidence boundary: cited main-article and results-supplement pages and retained page-linked evidence; protocol, Manual of Operations, SAP, external sources, and new-issue searches excluded
- Final disposition: 4 retained scientific issues, all Minor; 0 Major; 0 Uncertain; 1 Rejected

## Decision summary

| Candidate | Critic decision | Severity | Taxonomy | Basis |
|---|---|---|---|---|
| C-01 | Retained | Minor | Presentation inconsistency | The displayed GDB-status percentages use undisclosed nonmissing denominators rather than the population sizes in the column headers. |
| C-02 | Retained | Minor | Presentation inconsistency | Multiple B+S percentages reproduce a denominator of 321 although the column is headed n=322 and the table gives no alternate denominator. |
| C-03 | Retained | Minor | Presentation inconsistency | Table 1 and Figure 2 disagree by one participant in the surfactant-alone baseline FIO2 total for the same pretreatment variable. |
| C-04 | Retained | Minor | Presentation inconsistency | The eTable 4 abbreviation line expands RR as risk difference, contrary to the table header, row labels, and methods note. |
| C-05 | Rejected | Not applicable | Proposed arithmetic inconsistency | The compared disposition category and cumulative death outcome are not established as equivalent and use different nonmissing subsets. |

No retained finding is classified Major because the evidence establishes labeling, denominator-disclosure, or one-participant presentation errors, but does not establish a changed primary result, reversed inference, or materially altered conclusion.

## Retained scientific issues

### C-01 -- eTable 1 omits the denominators used for GDB-status percentages

- **Severity:** Minor
- **Category:** Presentation inconsistency
- **Location:** `joi250072supp4_prod_1761000786.6988.pdf`, PDF p.2, eTable 1, column headers and the rows under "GDB status (up to 120 days postnatal age), n (%)"; complete footnotes on the same page.
- **Source values/statements:** The headers report ITT `n=641`, ITT excluding untreated participants `n=635`, SAF `n=635`, and PP `n=617`. The four displayed status counts are respectively `340, 189, 16, 86`; `337, 189, 16, 86`; `337, 189, 16, 86`; and `329, 184, 15, 84`. The footnotes define the populations but do not state nonmissing GDB-status denominators or show a missing/unknown category.
- **Calculation/logical basis:** The status counts sum to `631`, `628`, `628`, and `612`, leaving differences of `10`, `7`, `7`, and `5` from the displayed population sizes. The printed percentages reproduce the smaller row-sum denominators: for example, `340/631=53.9%`, whereas `340/641=53.0%`; `337/628=53.7%`, whereas `337/635=53.1%`; and `329/612=53.8%`, whereas `329/617=53.3%`. The table therefore does not disclose the denominators actually used or account visibly for missing status.
- **Why retained:** The values and omission are directly visible, the arithmetic is valid, and the finding concerns presentation rather than the validity of participant outcomes.
- **Human verification instruction:** On Supplement 4 PDF p.2, sum the four GDB-status rows in each column and recompute the percentages with both the header n and the row sum; confirm whether nonmissing denominators or a missing/unknown row should be added.

### C-02 -- eTable 3 B+S percentages use n=321 despite a displayed n=322 header

- **Severity:** Minor
- **Category:** Presentation inconsistency
- **Location:** `joi250072supp4_prod_1761000786.6988.pdf`, PDF p.5, eTable 3, Budesonide + Surfactant column; continued table notes on PDF p.6.
- **Source values/statements:** The B+S column is headed `n=322`. It reports Experienced Any AEs `242 (75.4)`, Any of interest `240 (74.8)`, Hyperglycemia `214 (66.7)`, and Any fatal `22 (6.9)`. The notes define the safety population and monitoring rules but give no row-specific or nonmissing denominator for these entries.
- **Calculation/logical basis:** Using the displayed header gives `242/322=75.2%`, `240/322=74.5%`, `214/322=66.5%`, and `22/322=6.8%`. Using 321 gives the printed values after one-decimal rounding: `75.4%`, `74.8%`, `66.7%`, and `6.9%`. The repeated pattern supports an undisclosed denominator of 321 rather than isolated rounding error.
- **Why retained:** The mismatch is reproduced from several visible cells and is not resolved by the table notes. The intended correction is not inferred; the issue is the missing or inconsistent denominator presentation.
- **Human verification instruction:** Compare the B+S header and cited rows on PDF p.5 with the complete notes on p.6; confirm whether the AE denominator was 321 and then disclose it, use n/N, or correct the header/percentages.

### C-03 -- Table 1 and Figure 2 differ by one control participant for baseline FIO2

- **Severity:** Minor
- **Category:** Presentation inconsistency
- **Location:** `jama_ambalavanan_2025_oi_250072_1761000786.6838.pdf`, PDF p.6 / printed p.1457, Table 1 continuation, "FIO2 at baseline" and "High FIO2 (>=0.5) at baseline"; PDF p.9 / printed p.1460, Figure 2, "Baseline FIO2" subgroup and footnote c.
- **Source values/statements:** Table 1 reports B+S baseline FIO2 `[n=228]` with `86/228` high and surfactant-alone baseline FIO2 `[n=230]` with `81/230` high. Table 1 footnote b identifies the last available pretreatment respiratory data. Figure 2 reports B+S subgroup denominators `142` below 0.50 and `86` at or above 0.50, and surfactant-alone denominators `150` and `81`. Figure 2 footnote c calls FIO2 the last known pretreatment level and says 182 ITT participants lack baseline respiratory data.
- **Calculation/logical basis:** B+S reconciles: `142+86=228`. For surfactant alone, Table 1 implies `230-81=149` below 0.50, but Figure 2 reports 150 and totals `150+81=231`. Figure 2 totals `228+231=459`, consistent with `641-182=459`, whereas Table 1 totals `228+230=458`. The visible labels and footnotes identify the same pretreatment baseline FIO2 measure, and no note explains the one-participant difference.
- **Why retained:** The finding is a localized, document-grounded denominator inconsistency. It does not allege that either underlying participant classification is clinically or methodologically wrong.
- **Human verification instruction:** Compare Table 1 on PDF p.6 with the two Figure 2 baseline-FIO2 rows and footnote c on p.9; check the subgroup input to determine whether the surfactant-alone below-0.50 denominator is 149 or 150.

### C-04 -- eTable 4 incorrectly defines RR as risk difference

- **Severity:** Minor
- **Category:** Presentation inconsistency
- **Location:** `joi250072supp4_prod_1761000786.6988.pdf`, PDF p.7, eTable 4 header and binary estimate labels; PDF p.8, abbreviation line and methods note.
- **Source values/statements:** The header reads "Relative Risk (RR) or Mean Difference (MD) (95% CI)." Binary rows are labeled RR, including Death before 120 days PNA, `RR: 1.09 (0.76, 1.57)`. The p.8 methods note says binary outcomes report relative risks estimated by robust Poisson regression. The abbreviation line instead says `RR = risk difference`.
- **Logical basis:** The header, estimate labels, and analysis note consistently define RR as relative risk. Only the abbreviation line expands it as risk difference, making that line internally inconsistent.
- **Why retained:** This is an explicit document-internal terminology conflict in an allowed category. It does not require external statistical or clinical assumptions.
- **Human verification instruction:** Compare the eTable 4 header and RR-labeled estimates on p.7 with the abbreviation and binary-outcome methods lines on p.8; correct the abbreviation to `RR = relative risk`.

## Rejected and uncertain audit trail

### C-05 -- 120-day death counts differ within the displayed safety population

- **Critic decision:** Rejected
- **Proposed category:** Arithmetic inconsistency
- **Locations reviewed:** `joi250072supp4_prod_1761000786.6988.pdf`, PDF p.2, eTable 1; PDF pp.7-8, eTable 4 and notes; PDF pp.15-16, eTable 8 and notes.
- **Compared values:** eTable 1 gives 86 participants in the SAF "Death" GDB-status category among 628 displayed status records. eTables 4 and 8 give `50/321 + 44/313 = 94/634` for death before/by 120 days PNA.
- **Rejection basis:** eTable 1 presents a mutually exclusive GDB disposition distribution that also includes discharge, continued hospitalization, and transfer. eTables 4 and 8 describe cumulative all-cause in-hospital death through 120 days, and the compared tables use different nonmissing subsets (`628` versus `634`). The supplied pages do not establish that the GDB "Death" category must equal the cumulative death endpoint. Requiring `86=94` would therefore depend on an unsupported equivalence and participant-level mapping not present in the package evidence.
- **Human verification instruction:** Compare the GDB-status categories on p.2 with the clinical-outcome/death definitions on pp.8 and 15; do not treat 86 and 94 as the same measure unless participant-level status-to-death mapping establishes equivalence.

No verifier candidate remains Uncertain after the critic review.

## Critic-stage handoff

Advance C-01 through C-04 to report generation as Minor scientific findings. Preserve C-05 as Rejected. Do not add checker-level interpretations or search for new issues.
